Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Weiduning is a traditional Chinese medicine (TCM) antiviral preparation developed by the Guangzhou University of Chinese Medicine Tropical Medicine Research Institute. Formulated as nasal drops, it is specifically designed to treat the common cold, particularly the 'wind-heat pattern' as defined in traditional Chinese medicine diagnostics. The preparation is intended to provide localized therapeutic effects within the nasal mucosa, potentially through antiviral and anti-inflammatory mechanisms inherent to its herbal components. It has been evaluated in randomized, double-blind, placebo-controlled Phase 2 clinical trials in China to assess its efficacy and safety in adult patients presenting with common cold symptoms such as fever, sore throat, and nasal congestion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Weiduning.